A methylnickel(II) derivative of coenzyme F430 ( 1 ) was proposed as an intermediate in the enzymic process catalyzed by methyl‐CoM reductasc. Indirect evidence points to formation of CH 3 –F430M II in the reaction of F30M 1 (obtained from F430M II ( 2 )) with eleclrophilic methyl donors. The results presented here show, that such a compound does exist. A paramagnetic CD 3 –Ni II derivative 5b of the pentamethyl ester 2 (F430M) of coenzyme F430 was prepared by in situ methylation with (CD 3 ) 2 Mg and characterized by its isotropically shifted 2 H‐NMR spectrum. At −40°, the very broad D‐signal of the axially coordinated CD 3 group is found at −490 ppm. Comparison with the 2 H‐ and 1 H‐NMR spectra of mcthyl(tetramethylcyclam)nickel(II) derivatives 4 ([Ni II (CH 3 ))(tmc)]CF 3 SO 3 ( 4a ) is the only isolated CH 3 –Ni derivative of a N 4 macrocyclic Ni II complex' shows that the large isotropic shift to high field is characteristic for a Me group axially bound to the Ni center. The temperature dependence of the isotropic shift of the C D 3 –Ni group in both 4b and 5b follows Curie's law and yields 2 H hyperfine coupling constants of −0.65 ( 4b ) and −0.85 MHz ( 5b ), respectively. The 1 H‐NMR spectrum indicates that, in contrast to the five‐coordinate monochloro complex [Ni II Cl(tmc)] + , intermolecular exchange of the axial ligand in [Ni II (CH 3 )(tmc)] + 4a is either slow at the NMR time scale or does not occur at all.
No takes yet. Share an insight, caveat, or question.
Lin et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: